Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
31 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/31/3141915/18362/en/Amarin-Highlights-Key-Data-Providing-Mechanistic-Insights-into-Eicosapentaenoic-Acid-EPA-at-ESC-2025.html
25 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/25/3138380/18362/en/New-Analyses-from-REDUCE-IT-and-EPA-Mechanistic-Data-to-be-Presented-at-the-European-Society-of-Cardiology-ESC-Congress-2025.html
30 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/30/3123910/18362/en/Amarin-Reports-Second-Quarter-2025-Financial-Results.html
23 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/23/3120118/18362/en/Amarin-to-Report-Second-Quarter-2025-Financial-Results-and-Host-Conference-Call-on-July-30-2025.html
24 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/24/3104106/18362/en/Amarin-Announces-Exclusive-License-and-Supply-Agreement-with-Recordati-to-Commercialize-VAZKEPA-Icosapent-Ethyl-in-Europe.html
07 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/07/3075949/18362/en/Amarin-Reports-First-Quarter-2025-Financial-Results.html
ABOUT THIS PAGE